Sarah Donahue, MPH, NP, AOCNP
Articles
Novel Clinical Trials With ADCs in Gastric Cancer
October 13, 2022
Video
Before closing out their discussion on HER2+ gastric cancer, experts review clinical trials investigating other novel ADC agents in this setting.
Practice Pearls for Toxicity Management With ADC Therapy in Breast and Gastric Cancer
October 13, 2022
Video
Shared practical advice on the management of toxicities associated with antibody drug conjugate therapy in both the breast cancer and GI cancer settings.
T-DXd in HER2+ Gastric Cancer: Educating Patients About Risk of Diarrhea
October 06, 2022
Video
Comprehensive insight on the optimal management of diarrhea associated with ADC therapy, with regard to patient education and monitoring during treatment.
Role of the Broader Healthcare Team in Managing AEs Associated With T-DXd
October 06, 2022
Video
Panelists share their perspective on the role of the broader, multidisciplinary healthcare team in managing toxicity associated with trastuzumab deruxtecan therapy.
Ongoing Clinical Trials With T-DXd in HER2+ Gastric Cancer
September 29, 2022
Video
Panelists briefly review ongoing clinical trials with trastuzumab deruxtecan in the setting of HER2+ gastric cancers.
Patient Profile 4: A Patient with HER2+ Gastric Cancer Treated With T-DXd Who Develops Diarrhea
September 29, 2022
Video
Shifting focus to the second patient profile of HER2+ gastric cancer, key opinion leaders highlight the risk and management of diarrhea in this setting.
First- and Second-Line Treatment Options for HER2+ Gastric Cancer
September 22, 2022
Video
A broad overview of the treatment armamentarium for patients receiving first- or second-line therapy for HER2+ gastric cancer.
T-DXd in HER2+ Gastric Cancer: Managing Neutropenia and Other AEs
September 22, 2022
Video
Focused discussion on the management of antibody drug conjugate–related adverse events in gastric cancer, with a focus on neutropenia.
A Brief Review of Ongoing Clinical Trials of ADCs in Breast Cancer
September 15, 2022
Video
Before closing out their discussion on antibody drug conjugate use in breast cancer management, panelists consider ongoing clinical trials in this setting.
Patient Profile 3: A Patient with HER2+ Gastric Cancer Treated With T-DXd–who Develops Neutropenia
September 15, 2022
Video
Centering discussion on a patient profile of HER2+ gastric cancer, experts in oncology discuss the occurrence of neutropenia with trastuzumab deruxtecan therapy.